DJIA 17,798.57 79.57 0.45%
NASDAQ 4,713.63 11.76 0.25%
S&P 500 2,061.88 9.13 0.44%
market minute promo

Gilead Sciences (NASDAQ: GILD)

100.71 0.12 (0.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $100.69 0.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $102.21
Previous Close $100.59
Daily Range $100.08 - $102.51
52-Week Range $63.50 - $116.83
Market Cap $151.9B
P/E Ratio 17.84
Dividend (Yield) $0.00 (0.0%)
Volume 11,303,516
Average Daily Volume 16,774,421
Current FY EPS $7.93

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Biotech's 3 Most Influential CEOs

Top Motley Fool analysts weigh in on who they think are biotech's biggest power brokers.

5 Health Care Stocks That Need to Play Serious Catch Up

Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog

Notable ETF Inflow Detected - VTI, BAC, GILD, INTC

CNBC's Stock Pops & Drops From November 19

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

Why We're Huge Fans Of Gilead

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

Screening Pharma Stocks Amid Turnaround

Nasdaq 100 Movers: TSLA, SPLS

See More GILD News...

GILD's Top Competitors

GILD $100.71 (0.12%)
Current stock: GILD
AMGN $162.30 (-0.23%)
Current stock: AMGN
CELG $108.41 (0.99%)
Current stock: CELG
$0.00 (0.00%)
Current stock: